Senior Corporate Counsel

We’re partnering with a global, publicly traded life sciences manufacturing company on a Senior Corporate Counsel opportunity. Reporting directly to the General Counsel, this attorney will focus on SEC reporting, securities law, corporate governance, public-company disclosures, Section 16 matters, and related corporate legal responsibilities. The company is targeting a March 2027 start date.

This is a high-visibility role within a global Legal team spanning the U.S. and Italy, with regular interaction across Finance, Investor Relations, Internal Audit, senior leadership, external auditors, and outside counsel. The position is being added as the company continues to grow its U.S. presence and expand its public-company legal capabilities.

Responsibilities:

• Support the preparation and legal review of SEC filings, including Forms 20-F, 6-K, and other public-company disclosures
• Review earnings releases, investor presentations, financial disclosures, and external communications for consistency with SEC reporting requirements
• Support corporate governance, board and committee matters, governance policies, and related documentation
• Partner with Finance, Investor Relations, and Internal Audit on disclosure controls, reporting processes, certifications, and SOX-related matters
• Support Section 16 and insider reporting, including Forms 3, 4, and 5, transaction preclearance, insider-trading policies, and equity-related reporting
• Monitor developments across SEC regulations, NYSE requirements, securities laws, and corporate governance
• Advise business and senior leadership on public-company legal and disclosure matters
• Help improve legal and disclosure processes, reporting calendars, documentation, and cross-functional coordination as the U.S. organization continues to grow

Ideal background:

• Corporate and securities law experience within a law firm, publicly traded company, or combination of both
• J.D. and active membership in at least one U.S. state bar
• Strong hands-on experience with SEC reporting, securities law, public-company disclosures, and corporate governance
• Experience preparing or reviewing 10-K, 10-Q, 8-K, proxy, registration statement, or comparable public-company filings
• Experience with 20-F and 6-K filings is helpful but not required
• Exposure to Section 16, board/committee support, disclosure controls, SOX, insider trading, or equity compensation
• Experience within life sciences, biotechnology, pharmaceuticals, medical devices, manufacturing, or another regulated industry is preferred but not required